1. 384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas. (9th November 2020) Authors: Prawira, Amy; Coward, Jermaine; Mislang, Anna; Nagrial, Adnan; Gan, Hui; Jin, Xiaoping; Li, Baiyong; Wang, Zhongmin Maxwell; Kwek, Kon Yew; Xia, Dennis; Xia, Yu Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas. (10th December 2020) Authors: Prawira, Amy; Coward, Jermaine; Mislang, Anna; Nagrial, Adnan; Gan, Hui; Jin, Xiaoping; Li, Baiyong; Wang, Zhongmin Maxwell; Kwek, Kon Yew; Xia, Dennis; Xia, Yu Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial. Issue 4 (12th April 2022) Authors: Aggarwal, Charu; Prawira, Amy; Antonia, Scott; Rahma, Osama; Tolcher, Anthony; Cohen, Roger B; Lou, Yanyan; Hauke, Ralph; Vogelzang, Nicholas; P Zandberg, Dan; Kalebasty, Arash Rezazadeh; Atkinson, Victoria; Adjei, Alex A; Seetharam, Mahesh; Birnbaum, Ariel; Weickhardt, Andrew; Ganju, Vinod; Josh... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of travel distance on outcomes for clinical trial patients: the Kinghorn Cancer Centre experience. Issue 2 (3rd August 2022) Authors: Lim, Jennifer; Akbar Ali, Syafiq; Prawira, Amy; Sim, Hao‐Wen Journal: Internal medicine journal Issue: Volume 53:Issue 2(2023) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC). (5th April 2019) Authors: Hansen, Aaron R.; Tannock, Ian F.; Templeton, Arnoud; Chen, Eric; Evans, Andrew; Knox, Jennifer; Prawira, Amy; Sridhar, Srikala S.; Tan, Susie; Vera‐Badillo, Francisco; Wang, Lisa; Wouters, Bradly G.; Joshua, Anthony M. Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. Issue 2 (25th February 2022) Authors: Schöffski, Patrick; Tan, Daniel S W; Martín, Miguel; Ochoa-de-Olza, María; Sarantopoulos, John; Carvajal, Richard D; Kyi, Chrisann; Esaki, Taito; Prawira, Amy; Akerley, Wallace; De Braud, Filippo; Hui, Rina; Zhang, Tian; Soo, Ross A; Maur, Michela; Weickhardt, Andrew; Krauss, Jürgen; Deschler-Bai... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗